Online Educational Tool for Caregivers of Pediatric Oncology Patients
Online Educational Tool to Increase Knowledge and Decrease Anxiety in Caregivers of Pediatric Oncology Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Melanie Fields, M.D.
- Phone Number: 314-286-0344
- Email: fields_m@wustl.edu
Study Contact Backup
- Name: Shilpa Rampey Venkata Naga, M.D.
- Phone Number: 973-954-6149
- Email: rshilpa@wustl.edu
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Caregiver of a pediatric cancer patient who was recently diagnosed with cancer, including all pediatric malignancies. Multiple caregivers can be enrolled. Caregiver is defined as a person who is responsible for the direct care, protection, and supervision of the pediatric cancer patient. In this context, a caregiver is not required to be the parent or legal guardian.
Caregivers must have completed oncology nursing education either in the inpatient or outpatient setting.
- Inpatient setting: Before discharge from hospital after nursing education
- Outpatient setting: Within 15 days of discharge from the inpatient setting after nursing education or within 21 days of nursing education if diagnosis made in the outpatient setting
Exclusion Criteria:
- If less than 18 years of age
- Unable to utilize the electronic tool, complete the pre/post questionnaires and anxiety scale due to reading abilities, intellectual or physical disabilities.
- Cared for another child with cancer or secondary diagnosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Caregiver
After consent, the study visit will occur.
The study visit will consist of a brief set of demographic questions and a pre-game play knowledge assessment and anxiety assessment, followed by completion of the OncoWhiz game.
Immediately after utilizing OncoWhiz, the participant will complete a knowledge assessment and anxiety assessment, in addition to a satisfaction survey.
|
OncoWhiz is an online educational tool designed to supplement current institutional caregiver education.
OncoWhiz requires low graphical demands, has no-end user downloads, and is compatible with both desktop and mobile phones.
Questions are derived from the institutional binder and are written at a fifth-grade reading level for user accessibility.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Feasibility of using game-based tool to augment oncological education in caregivers of children newly diagnosed with cancer as measured by percentage of caregivers that enroll and complete study visit.
Time Frame: Through completion of study visit (Day 1) for all participants (estimated to be 1 year)
|
Through completion of study visit (Day 1) for all participants (estimated to be 1 year)
|
|
Feasibility of using game-based tool to augment oncological education in caregivers of children newly diagnosed with cancer as measured by the average time to completion of the educational tool.
Time Frame: Through completion of study visit (Day 1) for all participants (estimated to be 1 year)
|
Through completion of study visit (Day 1) for all participants (estimated to be 1 year)
|
|
Feasibility of using game-based tool to augment oncological education in caregivers of children newly diagnosed with cancer as measured by average time to complete the study visit.
Time Frame: Through completion of study visit (Day 1) for all participants (estimated to be 1 year)
|
Through completion of study visit (Day 1) for all participants (estimated to be 1 year)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine the impact of a game-based tool in decreasing anxiety of caregivers of children newly diagnosed with cancer as measured by change in anxiety.
Time Frame: Prior to OncoWhiz and after OncoWhiz (Day 1)
|
Anxiety will be quantified by the State-Trait Anxiety Inventory (STAI) Form.
Participants will answer 40 questions regarding how they generally feel.
There are 2 subscales within this assessment, both consisting of 20 separate items on a 4-point scale.
The State Anxiety Scale (Y-1) evaluates the current state of anxiety while the Trait Anxiety Scale (Y-2) evaluates anxiety-proneness as a personality trait.
A higher score indicates greater anxiety.
|
Prior to OncoWhiz and after OncoWhiz (Day 1)
|
|
Determine the impact of a game-based tool in increasing knowledge of caregivers of children newly diagnosed with cancer as measure by change in knowledge.
Time Frame: Prior to OncoWhiz and after OncoWhiz (Day 1)
|
The knowledge assessment consists of 20 multiple choice questions related to caregiving for children with cancer.
The percentage of questions answered correctly before and after utilization of the tool will be compared.
|
Prior to OncoWhiz and after OncoWhiz (Day 1)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Melanie Fields, M.D., Washington University School of Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 202207059
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.